DMC Biotechnologies
DMC Biotechnologies produces biobased specialty chemicals using microbial fermentation. The company, based in Boulder, Colorado and Durham, North Carolina, has developed a metabolic engineering process that simplifies biology to make fermentation more predictable, robust, and efficient. By unleashing the power of biology, DMC is on track to address two of the global challenges of our time: sustainably and affordably feeding a growing world population, and reducing greenhouse gas emissions through efficient production of (bio)chemicals.
Sector
Industrial Biotech
Strategies
Industrial Biotech
Status
Live
Website
dmcbio.com
Related News
Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform
DMC appoints Kelly Smith as VP R&D
DMC Announces First Close of Series B Financing, Raising $34 million
DMC Biotechnologies, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners
SofinnovaCapital
The Sofinnova Capital Strategy is our flagship fund, investing as founding or lead investor in early-stage biopharma and medtech start-ups developing groundbreaking therapeutic technologies.
SofinnovaMD Start
The Sofinnova MD Start Strategy is our in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy invests in growth-stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy invests in early-stage sustainable companies across the agriculture, chemicals, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy makes early-stage investments in leading Italian science for the benefit of patients around the world.
SofinnovaDigital Medicine
Our Digital Medicine Strategy backs early-stage techbio and healthtech start-ups at the intersection of biology, data, and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is our biotech accelerator, partnering with leading research organizations to create and build European biotech start-ups.